EXSIGHT VENTURES

exsight-ventures-logo

ExSight Ventures is a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions. The firm consists of 2 accomplished retinal surgeons and a team of investment professionals that have partnered to address the need for funding early-stage ophthalmic-focused companies. The firm seeks investments in biotechnology, medical devices, pharmaceuticals and software solutions in ophthalmology.

#SimilarOrganizations #People #Financial #More

EXSIGHT VENTURES

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical Venture Capital

Founded:
2015-09-01

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Google Apps For Business Register.com DNS Weebly Hosting


Similar Organizations

canna-holdings-logo

Canna Holdings

Canna Holdings invests in products and services within the medical cannabis industry.

core-clinical-logo

Core Clinical

Core Clinical is focuses on being the best medical imaging core laboratory in the industry.

sanitas-ventures-logo

Sanitas Ventures

SaSanitas Ventures is an invesment company that focuses on investing venture capital and private equity on eye care industries.

spire-bioventures-logo

Spire Bioventures

SPIRE Bioventures is a global player in the digital health/medical device/biotech industry.


Current Advisors List

randolph-cohen_image

Randolph Cohen Senior Advisor @ ExSight Ventures
Advisor

adam-benowitz_image

Adam Benowitz Senior Advisor @ ExSight Ventures
Advisor

Current Employees Featured

adam-benowitz_image

Adam Benowitz
Adam Benowitz Partner @ ExSight Ventures
Partner

james-murray_image

James Murray
James Murray Partner & Co-Founder @ ExSight Ventures
Partner & Co-Founder
2014-08-01

firas-rahhal_image

Firas Rahhal
Firas Rahhal Partner @ ExSight Ventures
Partner

alan-spiro_image

Alan Spiro
Alan Spiro Partner @ ExSight Ventures
Partner

randolph-cohen_image

Randolph Cohen
Randolph Cohen Partner @ ExSight Ventures
Partner

maneesha-ghiya_image

Maneesha Ghiya
Maneesha Ghiya Partner @ ExSight Ventures
Partner

not_available_image

Michael Nissen
Michael Nissen Partner @ ExSight Ventures
Partner

Founder


james-murray_image

James Murray

Investments List

Date Company Article Money raised
2021-03-01 DTx Pharma ExSight Ventures investment in Series B - DTx Pharma 100 M USD
2020-12-22 ONL Therapeutics ExSight Ventures investment in Series B - ONL Therapeutics 46.9 M USD
2020-06-02 Re-Vana Therapeutics ExSight Ventures investment in Seed Round - Re-Vana Therapeutics 3.25 M USD
2020-01-06 DTx Pharma ExSight Ventures investment in Series A - DTx Pharma 10.6 M USD
2019-07-16 Trefoil Therapeutics ExSight Ventures investment in Series A - Trefoil Therapeutics 28 M USD
2017-05-17 ONL Therapeutics ExSight Ventures investment in Series A - ONL Therapeutics 4.25 M USD
2017-05-01 LensGen ExSight Ventures investment in Series A - LensGen 21 M USD
2017-01-05 Trefoil Therapeutics ExSight Ventures investment in Series A - Trefoil Therapeutics 5.2 M USD
2015-11-12 RetroSense Therapeutics ExSight Ventures investment in Series B - RetroSense Therapeutics 6 M USD

More informations about "ExSight Ventures"

ExSight Ventures - Crunchbase Investor Profile

ExSight Ventures is a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions. The firm consists of 2 accomplished retinal surgeons and a team of investment โ€ฆSee details»

ExSight Ventures - LinkedIn

ExSight Ventures | 977 followers on LinkedIn. Investing to preserve and restore vision. | We are a venture capital firm specializing in early-stage impact investments in innovative ophthalmic โ€ฆSee details»

ExSight Ventures investment portfolio - PitchBook

ExSight Ventures General Information Company Description. Founded in 2014, Exsight Ventures is a venture capital firm based in New York, New York. The firm prefers to invest in biotechnology, ophthalmic diagnostic, treatment solutions, โ€ฆSee details»

Learn - ExSight Ventures

Our wide-ranging discussion touched on everything from the history and formation of ExSight, how we operate with two very busy vitreoretinal surgeons, our investment process, a pair of โ€ฆSee details»

ExSight Ventures - Investments, Portfolio & Company Exits

ExSight Ventures 's most notable exits include DTx Pharma and RetroSense Therapeutics. Unlock for free . Investments. Edit Investments Section. Number of Portfolio Organizations 8. โ€ฆSee details»

ExSight Ventures | Institution Profile - Private Equity International

ExSight Ventures. News, insights, analysis and data. ExSight Ventures overview. Founded in 2014, ExSight Ventures is a New York-based investment firm that targets early-stage โ€ฆSee details»

ExSight Ventures - Overview, News & Similar companies - ZoomInfo

ExSight Ventures invests in early-stage companies with innovative and impactful ophthalmic diagnostic and treatment solutions. The firm consists of two accomplished retinal surgeons โ€ฆSee details»

Exsight Ventures - Portfolio, Partners, Reviews, News

Jan 20, 2022 We are a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions. The firm consists of 2 accomplished โ€ฆSee details»

ExSight Ventures - venturecapitalarchive.com

ExSight Ventures is a leading early stage ophthalmic investor focused on life sciences venture Capital. The firm specializes in early stage investments in innovative ophthalmic diagnostic โ€ฆSee details»

ExSight Ventures Raises Fourth Venture Capital Fund to Invest in โ€ฆ

Jan 9, 2025 Co-leading the Horizon Surgical Systems $30M+ Series A: The financing was led by ExSight Ventures and a major corporate investor, with participation from Main Street Advisors, โ€ฆSee details»

ExSight Ventures - Contacts, Employees, Board Members

ExSight Ventures has 7 current employee profiles, including Partner Adam Benowitz. ExSight Ventures has 2 board members and advisors, including Randolph Cohen. Contacts. Edit โ€ฆSee details»

ExSight Ventures - Private Equity List

ExSight Ventures. Investor type. VC. Founded. 2014See details»

Corporate Venturing - Definition, Benefits, Examples

Earnings will then be reinvested in new ventures where future returns are expected. #5 Mergers and Acquisitions. This involves financing a startup companyโ€™s acquisitions through an โ€ฆSee details»

Blog โ€” ExSight Ventures

ExSight Ventures portfolio companies featured prominently as well. Let's jump into key highlights from the meeting. Read More. James Murray 2/8/24 James Murray 2/8/24. 2023 Year in โ€ฆSee details»

Meet the 2025 Access Ventures Fellows โ€” Access Ventures

2 days ago In 2025, the organization will serve nearly 3,000 people experiencing homelessness across 30 cities in California. This summer, Zac will graduate with a masterโ€™s in urban planning โ€ฆSee details»

BENEFIT VENTURES CORPORATION - WOODBRIDGE, NJ

BENEFIT VENTURES CORPORATION B. BENEFIT VENTURES CORPORATION CLAIM THIS BUSINESS. 1480 ROUTE 9 N STE 203 WOODBRIDGE, NJ 07095 Get Directions (732) 855 โ€ฆSee details»

EASTHAVEN VENTURES LLC Brandon MS, 39042 - Company โ€ฆ

Easthaven Ventures LLC. Contact Information. 1490 W Government St, Ste 7. Brandon, MS 39042-3024 VIEW MAP. Company Details. Location Type: Single Location Ownership: Private โ€ฆSee details»

2023 Year in Review โ€” ExSight Ventures

Feb 8, 2024 ExSight Ventures is thrilled to share a few of our 2023 highlights: DTx Pharmaโ€™s FALCONโ„ข soared to a Novartis acquisition: DTx Pharma, an ExSight portfolio company, โ€ฆSee details»

Home - Competitive Power Ventures

Responsible EnergyStarts with Us With 25 years of unparalleled success, CPV has a history of applying our expertise to build the next generation of technologies while contributing to grid โ€ฆSee details»

EXSIGHT ADDS 60% TO FUND 3 INCLUDING A LEADING EYE CARE โ€ฆ

Nov 2, 2023 ExSight Ventures, a specialized ophthalmic-focused venture capital firm, is thrilled to announce a significant increase in capital for its most recent dedicated ophthalmology fund. โ€ฆSee details»

linkstock.net © 2022. All rights reserved